SCHEMBL19463045

SCHEMBL19463045

CCOCCOCCOCCO[C@@H]1O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(C)=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.62
▸ MAPT P10636 1/20 0.62
▸ CYP2C9 P11712 1/20 0.62
▸ CYP2C19 P33261 1/20 0.62
▸ POLB P06746 2/20 0.57
▸ LMNA P02545 3/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ ALDH1A1 P00352 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.48
▸ CYP2D6 P10635 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ NR3C1 P04150 1/20 0.44
▸ FYN P06241 1/20 0.44
▸ ADRA2A P08913 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ ADRA2B P18089 1/20 0.44
▸ DRD4 P21917 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ CA2 P00918 6/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24531302 1.00 CYP3A4 (0.62) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL24239926 1.00 CYP3A4 (0.62) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL23618355 1.00 CYP3A4 (0.62) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL10082992 1.00 CYP3A4 (0.62) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL24531300 1.00 CYP3A4 (0.62) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL17235452 0.95 CYP3A4 (0.60) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL18769699 0.95 CYP3A4 (0.60) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL21919751 0.95 CYP3A4 (0.60) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL19477766 0.95 CYP3A4 (0.60) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL19501230 0.95 CYP3A4 (0.60) CYP3A4MAPTCYP2C9CYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3443092-A1 TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS Arbutus Biopharma Corporation (CA) 2019-02-20 — — EP disclosed
WO-2017177326-A1 TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS PROTIVA BIOTHERAPEUTICS, INC. (CA) 2017-10-19 — — WO disclosed
Send feedback